Cargando…

Medications for opioid use disorder during incarceration and post-release outcomes

BACKGROUND: Continuation or initiation of MOUDs during incarceration could improve post-release outcomes by preventing return to opioid use and reducing risk of overdose. People with OUD involved in the criminal legal system are a vulnerable population, yet little research has comprehensively examin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cates, Lara, Brown, Aaron R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898706/ https://www.ncbi.nlm.nih.gov/pubmed/36737503 http://dx.doi.org/10.1186/s40352-023-00209-w

Ejemplares similares

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
por: Chatterjee, Avik, et al.
Publicado: (2023)

Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder
por: Chappuy, Mathieu, et al.
Publicado: (2021)

Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder
por: Fox, Aaron D, et al.
Publicado: (2015)

Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration
por: Cadet, Techna, et al.
Publicado: (2023)

COVID-19 and treating incarcerated populations for opioid use disorder
por: Donelan, Christopher J., et al.
Publicado: (2021)

Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
por: Russell, Cayley, et al.
Publicado: (2022)

Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review
por: Malta, Monica, et al.
Publicado: (2019)

A Randomized Controlled Trial of a Parent Management Training Program for Incarcerated Parents: Post-Release Outcomes
por: Eddy, J. Mark, et al.
Publicado: (2022)

Emergency room use after being released from incarceration
por: Erlyana, Erlyana, et al.
Publicado: (2014)

Association of Restrictive Housing During Incarceration With Mortality After Release
por: Brinkley-Rubinstein, Lauren, et al.
Publicado: (2019)

Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration
por: Palis, Heather, et al.
Publicado: (2022)

Predicting quality of life during and post detention in incarcerated juveniles
por: de Ruigh, E. L., et al.
Publicado: (2019)

Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021
por: Miele, Kathryn, et al.
Publicado: (2023)

The perfect storm: COVID-19, mass incarceration and the opioid epidemic
por: Mukherjee, Trena I., et al.
Publicado: (2020)

Ethical inclusion: Risks and benefits of research from the perspective of perinatal people with opioid use disorders who have experienced incarceration
por: Reddy, Julia, et al.
Publicado: (2023)

Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health
por: Sugarman, Olivia K., et al.
Publicado: (2020)

Therapeutic Community Treatment of an Inmate Population with Substance Use Disorders: Post-Release Trends in Re-Arrest, Re-Incarceration, and Drug Misuse Relapse
por: Galassi, Alexandra, et al.
Publicado: (2015)

Prescribers’ satisfaction with delivering medications for opioid use disorder
por: Knudsen, Hannah K., et al.
Publicado: (2021)

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2022)

Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder
por: Belcher, Annabelle M., et al.
Publicado: (2021)

Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
por: Marciuch, Anne, et al.
Publicado: (2023)

Medication Treatment for Opioid Use Disorders:: A Brief Overview with Comments on Extended Release Naltrexone
por: Woody, George
Publicado: (2017)

Educating the community about the opioid epidemic and medications for opioid use disorder
por: Williams, Jill M., et al.
Publicado: (2022)

Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers
por: Sung, Minhee L., et al.
Publicado: (2022)

A conceptual model for understanding post-release opioid-related overdose risk
por: Joudrey, Paul J., et al.
Publicado: (2019)

Factors associated with changes in illicit opioid use during the COVID-19 pandemic among incarcerated people who use drugs in Quebec, Canada
por: Park, Hyejin, et al.
Publicado: (2022)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021
por: Jones, Christopher M., et al.
Publicado: (2023)

Mass incarceration and the impact of prison release on HIV diagnoses in the US South
por: Ojikutu, Bisola O., et al.
Publicado: (2018)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder
por: Kranzler, Henry R, et al.
Publicado: (2020)

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
por: Greenwald, Mark K., et al.
Publicado: (2023)

Retention in HIV care during the 3 years following release from incarceration: A cohort study
por: Loeliger, Kelsey B., et al.
Publicado: (2018)

Prevalence Rates and Evolution of Psychiatric Disorders Among Incarcerated Youths in Comparison With Non-incarcerated Youths
por: Heller, Patrick, et al.
Publicado: (2022)

Illicit substance use after release from prison among formerly incarcerated primary care patients: a cross-sectional study
por: Chamberlain, Adam, et al.
Publicado: (2019)

Overview of Substance Use Disorders and Incarceration of African American Males
por: Mukku, Venkata K., et al.
Publicado: (2012)

Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder
por: Parlier-Ahmad, Anna Beth, et al.
Publicado: (2021)

Reducing overdose after release from incarceration (ROAR): study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison
por: Waddell, Elizabeth Needham, et al.
Publicado: (2020)

Diagnosis of Biceps Incarceration: Observations on the Biceps Incarceration Maneuver
por: Knapik, Derrick M., et al.
Publicado: (2021)

Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado
por: Amura, Claudia R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tveeshn7poc1iqorm6c8d6vn66